Use of cryptosporidium cgd6_2310 protein as an oocyst outer wall marker protein
By using Cryptosporidium cgd6_2310 protein as a marker protein for the outer wall of the oocyst, a specific antibody was prepared, which solved the problem of low sensitivity in existing Cryptosporidium detection methods and achieved efficient and economical oocyst wall detection, suitable for monitoring environmental and clinical samples.
Patent Information
- Application Number
- CN202210804248.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-07-09
- Publication Date
- 2026-02-03
- Estimated Expiration
- 2042-07-09
AI Technical Summary
The lack of specific antibodies in existing technologies for labeling the outer wall of Cryptosporidium oocysts results in low sensitivity and high cost in Cryptosporidium detection methods, making them difficult to apply on a large scale, especially when the oocyst content in environmental water samples is diluted.
Cryptosporidium cgd6_2310 protein was used as a marker protein for the outer wall of the oocyst. Specific antibodies were prepared and detected by indirect immunofluorescence. The application of recombinant protein and peptide antibodies was combined to achieve specific recognition and enrichment of the oocyst wall.
It improves the sensitivity and specificity of Cryptosporidium detection, reduces detection costs, and is suitable for efficient monitoring of environmental water samples and clinical samples, with broad application potential.